Gas Embolism With Use of Argon Plasma Coagulation

Embolism, Air Clinical Trial

Official title:
Gas Embolism With Use of Argon Plasma Coagulation

Status Completed

Clinical Trial Summary

The purpose of this study is to use transesophageal echocardiography (TEE) to determine the incidence, severity, and clinical significance of gas bubbles during argon plasma coagulation (APC).

Clinical Trial Description

Gas embolism is a rare but serious complication of APC. We will use TEE to monitor for gas bubbles during APC. APC will be terminated if gas bubbles are associated with ischemic heart rhythms, wall motion abnormalities, or if large gas bubbles are noted in the left ventricle. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00676858
Study type	Observational
Source	Beth Israel Deaconess Medical Center
Contact
Status	Completed
Phase	N/A
Start date	July 2008
Completion date	July 5, 2011

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT03720184` - Haemo-autologous Antegrade Repriming (HAR) as Minimum Impact Perfusion Strategy for Cardiopulmonary Bypass	N/A
	Recruiting	`NCT00862160` - Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit	Phase 4